Trazodone Cost in New Jersey (2026): Prices, Insurance, and Savings

What Does Trazodone Actually Cost at New Jersey Pharmacies?

Generic trazodone is among the most affordable prescription medications sold in New Jersey, with retail cash prices averaging $10 per month for a standard 30-tablet supply in 2026. The manufacturer's list price for branded trazodone sits around $40 per month, but almost no one pays that figure because generic versions have been available since 1986.

Price variation across New Jersey pharmacies is real but modest. A 30-count supply of trazodone 50 mg tablets ranges from roughly $4 at warehouse pharmacies like Costco and Walmart in Edison or Cherry Hill to approximately $15 at independent pharmacies in smaller municipalities. CVS, Walgreens, and Rite Aid locations across the state generally price a month's supply between $8 and $12 without insurance or coupons. The medication's inclusion on most $4 generic lists means that even patients paying entirely out of pocket face minimal financial burden. Trazodone has been off-patent for nearly four decades, and the FDA's Orange Book lists over a dozen approved generic manufacturers, which keeps competitive pricing pressure high [1].

For patients prescribed higher doses (150 mg or 300 mg tablets for depression rather than insomnia), monthly costs may rise to $15 to $25 depending on tablet strength and quantity. The cost per milligram decreases with higher-strength tablets, so a single 150 mg tablet is cheaper than three 50 mg tablets.

Does New Jersey Medicaid Cover Trazodone?

Yes. New Jersey's Medicaid program, administered through NJ FamilyCareFDA, covers trazodone with prior authorization. The prior authorization requirement applies to most psychotropic medications in the state's preferred drug list, but approvals for trazodone are routine because of the drug's extensive safety record and low cost.

NJ Medicaid beneficiaries typically pay $0 to $3 in copays for generic trazodone, depending on their specific plan and income bracket. The Centers for Medicare and Medicaid Services reports that trazodone ranks among the top 25 most-prescribed medications nationwide, and state Medicaid programs nearly universally include it on formulary [2]. For NJ FamilyCare members, the prescriber submits the PA request electronically, and most approvals come back within 24 to 72 hours. Denials are uncommon when the indication is documented as either major depressive disorder or chronic insomnia with inadequate response to sleep hygiene.

Patients enrolled in NJ Medicaid managed care organizations (Amerigroup, Horizon NJ Health, UnitedHealthcare Community Plan, or WellCare) should verify their specific plan's formulary, as each MCO maintains a slightly different preferred drug list. All four currently list generic trazodone, though PA requirements and step-therapy protocols may differ.

How NJ Commercial Insurance Plans Handle Trazodone

Most commercial health insurance plans sold in New Jersey place generic trazodone on Tier 1, the lowest-cost formulary tier. That means copays between $0 and $15 for a 30-day supply. Plans from Horizon Blue Cross Blue Shield of New Jersey, Aetna, Cigna, and UnitedHealthcare all list trazodone as a preferred generic without prior authorization for the majority of their individual and employer-sponsored products.

The Affordable Care Act requires all plans sold on the NJ marketplace (GetCovered.NJ.gov) to cover mental health medications as an essential health benefit. Because trazodone carries an FDA-approved indication for major depressive disorder [1], it falls squarely within that mandate. Even plans with restrictive formularies include at least one trazodone formulation.

For patients with high-deductible health plans (HDHPs), trazodone's low cash price works in their favor. Paying $10 out of pocket each month while the deductible accumulates costs less than many specialty copays. Some HDHPs in New Jersey allow preventive drug lists that cover certain generics at $0 before the deductible is met. Check whether your plan's preventive drug list includes trazodone, particularly if it was prescribed for a condition classified as preventive care.

Medicare Part D plans in New Jersey also cover trazodone. The 2026 Medicare Part D formulary requirements mandate coverage of antidepressants as a protected class, meaning plans cannot exclude trazodone or require fail-first on another drug before approving it [3].

Is Compounded Trazodone Legal in New Jersey?

Compounded trazodone is legal in New Jersey when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits pharmacies to compound medications when a prescriber determines that a commercially available product does not meet a patient's specific medical needs [4].

New Jersey's Board of Pharmacy regulates 503A compounding pharmacies under N.J.A.C. 13:39. Common reasons a prescriber might order compounded trazodone include the need for a liquid suspension (useful for patients who cannot swallow tablets), a custom dose strength not commercially available, or a formulation free of specific dyes or fillers that cause allergic reactions.

The cost of compounded trazodone in New Jersey varies by pharmacy and formulation. Simple capsule compounding may add $10 to $20 above the cost of commercial generics, while specialty liquid formulations can run $30 to $60 per month. Insurance coverage for compounded medications is inconsistent. Most commercial plans and Medicaid do not cover compounded drugs unless the prescriber documents medical necessity and the plan has a compounding benefit.

503B outsourcing facilities, which produce larger batches under FDA oversight, also operate in the New Jersey market. These facilities supply some telehealth platforms and clinics with compounded trazodone formulations, though availability fluctuates based on FDA inspection outcomes and ingredient sourcing.

Getting Trazodone via Telehealth in New Jersey

New Jersey permits telehealth prescribing of trazodone. The state's Telehealth Access Act (P.L. 2020, c.3) established a permanent framework for telemedicine that survived the pandemic-era temporary expansions, and prescribing controlled and non-controlled medications via audio-video visits is standard practice [5].

Trazodone is not a controlled substance under federal law or the New Jersey Controlled Dangerous Substances Act, which simplifies the telehealth prescribing pathway. Providers do not need an in-person evaluation before writing a trazodone prescription via telehealth, unlike Schedule II through V medications that may carry additional verification requirements.

Multiple telehealth platforms operating in New Jersey prescribe trazodone for insomnia and depression. The typical workflow involves a synchronous video visit with a licensed NJ prescriber, followed by an electronic prescription sent to the patient's preferred pharmacy. Visit costs range from $50 to $150 without insurance, and most NJ commercial plans now cover telehealth visits at the same copay as in-person visits under the state's telehealth parity law.

A 2005 study by Mendelson published in the Journal of Clinical Psychiatry demonstrated that trazodone 50 mg improved sleep efficiency and reduced wake-after-sleep-onset time in patients with primary insomnia, supporting its widespread off-label use for sleep disorders [6]. This evidence base underpins the confidence NJ telehealth providers have in prescribing it remotely for insomnia complaints.

Discount Programs and Savings Strategies for NJ Residents

Several pathways exist to reduce trazodone costs below the already-low $10 per month average in New Jersey. The most reliable options require no insurance at all.

Pharmacy discount cards and apps. GoodRx, RxSaver, and similar platforms show real-time pricing at NJ pharmacies. Trazodone 50 mg, 30 tablets, regularly prices between $4 and $9 through these programs at chains including Walmart, Costco, ShopRite, and Stop & Shop pharmacies across the state. The discount comes from pre-negotiated rates with pharmacy benefit managers and is free for the patient.

$4 generic programs. Walmart and ShopRite (through its free/low-cost generic program) include trazodone on their $4-for-30-day and $10-for-90-day generic medication lists. No insurance or coupon is needed. The patient simply presents the prescription and requests the generic program pricing.

NJ Pharmaceutical Assistance to the Aged and Disabled (PAAD). New Jersey residents 65 and older, or those receiving Social Security disability, with income below $38,769 (single) or $47,516 (married) may qualify for PAAD, which covers generic medications with a $5 copay [7]. The program is administered by the NJ Department of Human Services.

Senior Gold Prescription Discount Program. For NJ residents whose income slightly exceeds PAAD limits, the Senior Gold program provides a 50% discount on medications at participating pharmacies. Trazodone under this program typically costs $5 or less per month.

Mark Cuban Cost Plus Drug Company. Cost Plus Drugs offers trazodone 50 mg (30 tablets) at its manufacturing cost plus a 15% margin, a $5 pharmacy fee, and shipping. The total lands around $5 to $7 delivered to any New Jersey address.

Trazodone Pricing Compared to Other Sleep Medications in NJ

Trazodone's cost advantage over other prescription insomnia treatments is substantial. A side-by-side comparison with medications commonly prescribed for the same indication shows why trazodone remains a first-line choice for cost-conscious prescribers and patients.

Generic zolpidem (Ambien) costs $8 to $15 per month in New Jersey, comparable to trazodone but carrying Schedule IV controlled substance restrictions that complicate telehealth prescribing and refills. Suvorexant (Belsomra), a dual orexin receptor antagonist, costs $350 to $450 per month without insurance. Lemborexant (Dayvigo) runs similarly high at $300 to $400 monthly. Even with insurance, Tier 3 copays for these branded agents often exceed $50.

The American Academy of Sleep Medicine's 2017 clinical practice guideline for chronic insomnia recommended cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, with pharmacotherapy reserved for patients who do not respond adequately [8]. Among pharmacologic options, trazodone's favorable cost profile, non-controlled status, and Mendelson's 2005 data showing improved sleep architecture make it a practical second-line choice, especially for patients who cannot access or afford CBT-I [6].

A 2017 systematic review published in the Journal of Clinical Medicine examined trazodone's efficacy for insomnia across multiple trials, reporting that doses of 25 to 150 mg improved subjective sleep quality and total sleep time, though evidence quality varied [9]. "Trazodone remains one of the most commonly prescribed medications for insomnia in the United States, despite its off-label status for this indication," noted the review authors.

The Endocrine Society's clinical practice guidelines recognize that sleep disruption affects hormonal regulation, including testosterone, cortisol, and growth hormone secretion [10]. For patients managing hormonal therapies alongside sleep complaints, trazodone's minimal impact on the hypothalamic-pituitary axis makes it a favorable adjunct.

What to Know Before Filling a Trazodone Prescription in NJ

New Jersey pharmacies dispense trazodone as immediate-release tablets (50 mg, 100 mg, 150 mg, 300 mg) and, less commonly, extended-release tablets (150 mg, 300 mg branded as Oleptro, now discontinued but with remaining generic stock). The immediate-release formulation is the standard for both depression and insomnia dosing.

Common starting doses for insomnia range from 25 mg (half of a scored 50 mg tablet) to 100 mg taken 30 minutes before bedtime. For major depressive disorder, therapeutic doses typically reach 150 to 400 mg daily, divided or given at bedtime [1]. The FDA-approved labeling recommends starting at 150 mg/day in divided doses for depression, with increases of 50 mg/day every 3 to 4 days as tolerated.

Side effects relevant to cost decisions include morning sedation (reported in 15 to 20% of patients at higher doses), orthostatic hypotension, and rare but serious priapism (estimated incidence of 1 in 6,000 to 1 in 8,000 male patients) [1]. The FDA's safety communication on trazodone includes a boxed warning about suicidality risk in patients under 25, consistent with all antidepressant labeling [1].

Dr. Thomas Roth, Director of the Sleep Disorders Center at Henry Ford Hospital, has stated: "Trazodone's popularity for insomnia reflects a pragmatic clinical reality. It is inexpensive, non-addictive, and most patients tolerate low doses well, even though rigorous long-term efficacy data for insomnia are limited."

For NJ patients weighing cost against alternatives, the math is straightforward: trazodone at $10 per month or less, versus $50+ for branded sleep agents. At 90-day fills through mail-order or $10 generic programs, the annual cost of trazodone therapy drops below $40. That figure is difficult for any competing insomnia medication to match.